Neuralink, the tech company founded by Elon Musk has achieved yet another breakthrough with the 3rd implantation of its brain-computer interface (BCI) device, the Neuralink brain chip.
Elon Musk’s brain-child, Neuralink, is making strides toward a future where human brains and computers are seamlessly connected. At the CES 2025 event, Musk confirmed that the company has successfully implanted its brain-computer interface (BCI) device in a third patient — and that it’s just the beginning. He stated,
‘we’ve now got three humans with Neuralinks implanted, and they’re all working well.”
Further, he revealed plans to perform 20 to 30 more implants this year 2025.
Neuralink’s BCI tech involves a coin-sized device implanted in the brain, equipped with thin electrodes that detect and interpret neural signals. These signals are then wirelessly transmitted to external devices, enabling users to control computers, smartphones, or even robotic limbs through that alone. The procedure itself is minimally invasive, involving a specialized surgical robot that carefully inserts electrodes while avoiding blood vessels to reduce risk. We further discuss this in, A deep Dive into Elon Musk’s Neuralink Technology.
The first implant occurred in January 2024 with patient Noland Arbaugh who had been paralyzed from the shoulders down following a driving accident. Feedback from Noland indicated the ability to interact with digital devices using his thoughts, significantly enhancing the quality of his life.
However, this first design faced some electrodes detaching over time, which led to a refinement of the original design and algorithms.
From here, neuralink registered two studies with the U.S. Food and Drug Administration (FDA). The first, known as the PRIME study (Precise Robotically Implanted Brain-Computer Interface), involved five patients with paralysis to enable them to control external devices through their thoughts. The second study, Convoy, focuses on three patients and aims to facilitate control of assistive devices such as robotic arms all via the BCI.
Neuralink’s successful implantation of its BCI device in a third patient shows progress in integrating neurotechnology into human augmentation. With plans to expand this year, all we can do is wait for news and outcomes, who knows, we are in the age of Technology after all.
